Scientific research support required for CCR EIB projects; melina frantzeskakis meets this need; period of performance: 1 year (NTE 1980 HRS); POP 8/24/2020 - 8/23/2021; astrix proposal number…
Ended Awarded Last action
- Contract number
- 75N91020F00043
- Awardee
-
Astrix Technology LLC UEI NRVNN8E6NCK4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $90,308
Award facts
- Contract value 100% obligated
- $90,307.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$2,436 | |
| Original award | $92,743 |
About this award
The National Cancer Institute (NCI), a civilian agency under the National Institutes of Health, awarded a Blanket Purchase Agreement (BPA) call contract to Astrix Technology LLC for scientific research support services required for CCR (Cancer Causation and Relevant Therapeutic Research) EIB projects. The contract, valued at $90,307.52 on a firm fixed price basis, was awarded on August 24, 2020, with a period of performance from August 24, 2020, through August 23, 2021, not-to-exceed 1,980 hours. The specific resource provided under this contract was Melina Frantzeskakis, whose qualifications and statement of work were submitted as part of ASTRIX proposal number 20200721-NCI001. The work is to be performed in Bethesda, Maryland. No small business set-aside designation was applied to this award, indicating Astrix Technology competed on an unrestricted basis under the NIH's Multiple Award Schedule (MAS) contracting vehicle.
Astrix Technology LLC, a for-profit limited liability company headquartered in Red Bank, New Jersey, specializes in providing scientific, research, technical, and administrative support services to federal agencies. The company has been registered in the System for Award Management (SAM.gov) since 2002 and maintains a significant presence as a prime contractor across multiple NIH institutes. Beyond this individual BPA call, Astrix Technology holds a $20 million single-award BPA with NIH's Office of Logistics and Acquisition Operations through May 31, 2025, demonstrating substantial ongoing capability to support NCI and other federal biomedical research initiatives. The ultimate completion date for this specific task order was established as December 27, 2024, with a recent de-obligation action taken to clear expiring FY2020 funding lines per NIH Office of Acquisition and Logistics Management communication dated November 5, 2024.
Description
Scientific research support required for CCR EIB projects; melina frantzeskakis meets this need; period of performance: 1 year (NTE 1980 HRS); POP 8/24/2020 - 8/23/2021; astrix proposal number 20200721-NCI001, SOW & frantzeskakis' CV attache
Quick answers
Who was awarded contract 75N91020F00043?
75N91020F00043 was awarded to Astrix Technology LLC by National Cancer Institute (National Institutes of Health) on August 24, 2020.
How much is contract 75N91020F00043 worth?
The government has obligated $90,308 on 75N91020F00043.
Is contract 75N91020F00043 an order under another contract?
Yes. 75N91020F00043 is a BPA call under GS07F147DA-HHSN261201700002B, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75N91020F00043 competed?
The extent of competition for 75N91020F00043 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award